• Western blot analysis of lysates from HepG2 cells treated with EGF 200ng/ml 30', using FGFR1 (Phospho-Tyr766) Antibody. The lane on the right is blocked with the phospho peptide.
  • Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using FGFR1 (Phospho-Tyr766) Antibody. The picture on the right is blocked with the phospho peptide.

Anti-Phospho-FGFR1-Tyr766 antibody (736-785 aa) (STJ90810)

SKU:
STJ90810

Current Stock:
Host: Rabbit
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Phospho-Fibroblast growth factor receptor 1-Tyr766 (736-785 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
ELISA 1:5000
IF 1:50-200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: FGFR1
Gene ID: 2260
Uniprot ID: FGFR1_HUMAN
Immunogen Region: 736-785 aa
Specificity: Phospho-Flg (Y766) Polyclonal Antibody detects endogenous levels of Flg protein only when phosphorylated at Y766.
Immunogen: The antiserum was produced against synthesized peptide derived from the human FGFR1 around the phosphorylation site of Tyr766 at the amino acid range 736-785
Post Translational Modifications Autophosphorylated. Binding of FGF family members together with heparan sulfate proteoglycan or heparin promotes receptor dimerization and autophosphorylation on tyrosine residues. Autophosphorylation occurs in trans between the two FGFR molecules present in the dimer and proceeds in a highly ordered manner. Initial autophosphorylation at Tyr-653 increases the kinase activity by a factor of 50 to 100. After this, Tyr-583 becomes phosphorylated, followed by phosphorylation of Tyr-463, Tyr-766, Tyr-583 and Tyr-585. In a third stage, Tyr-654 is autophosphorylated, resulting in a further tenfold increase of kinase activity. Phosphotyrosine residues provide docking sites for interacting proteins and so are crucial for FGFR1 function and its regulation. Ubiquitinated. FGFR1 is rapidly ubiquitinated by NEDD4 after autophosphorylation, leading to internalization and lysosomal degradation. CBL is recruited to activated FGFR1 via FRS2 and GRB2, and mediates ubiquitination and subsequent degradation of FGFR1. N-glycosylated in the endoplasmic reticulum. The N-glycan chains undergo further maturation to an Endo H-resistant form in the Golgi apparatus.
Function Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.
Protein Name Fibroblast Growth Factor Receptor 1
Fgfr-1
Basic Fibroblast Growth Factor Receptor 1
Bfgfr
Bfgf-R-1
Fms-Like Tyrosine Kinase 2
Flt-2
N-Sam
Proto-Oncogene C-Fgr
Cd Antigen Cd331
Database Links Reactome: R-HSA-109704
Reactome: R-HSA-1257604
Reactome: R-HSA-1839120
Reactome: R-HSA-1839122
Reactome: R-HSA-190370 P11362-19
Reactome: R-HSA-190373 P11362-1
Reactome: R-HSA-190374 P11362-1
Reactome: R-HSA-2219530
Reactome: R-HSA-375165 P11362-1
Reactome: R-HSA-445144 P11362-1
Reactome: R-HSA-5654219
Reactome: R-HSA-5654687
Reactome: R-HSA-5654688
Reactome: R-HSA-5654689
Reactome: R-HSA-5654693
Reactome: R-HSA-5654726
Reactome: R-HSA-5655302
Reactome: R-HSA-5673001
Reactome: R-HSA-6811558
Reactome: R-HSA-8853336
Reactome: R-HSA-9758919
Reactome: R-HSA-9793380
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Nucleus
Cytoplasm
Cytosol
Cytoplasmic Vesicle
After Ligand Binding
Both Receptor And Ligand Are Rapidly Internalized
Can Translocate To The Nucleus After Internalization
Or By Translocation From The Endoplasmic Reticulum Or Golgi Apparatus To The Cytosol
And From There To The Nucleus
Alternative Antibody Names Anti-Fibroblast Growth Factor Receptor 1 antibody
Anti-Fgfr-1 antibody
Anti-Basic Fibroblast Growth Factor Receptor 1 antibody
Anti-Bfgfr antibody
Anti-Bfgf-R-1 antibody
Anti-Fms-Like Tyrosine Kinase 2 antibody
Anti-Flt-2 antibody
Anti-N-Sam antibody
Anti-Proto-Oncogene C-Fgr antibody
Anti-Cd Antigen Cd331 antibody
Anti-FGFR1 antibody
Anti-BFGFR antibody
Anti-CEK antibody
Anti-FGFBR antibody
Anti-FLG antibody
Anti-FLT2 antibody
Anti-HBGFR antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance